REGISTERED NUMBER: 08184604 (England and Wales)

EXCELSIOR SCIENTIFIC LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

Page

Balance Sheet

1

FIXED ASSETS

8,316

5,538

CURRENT ASSETS

32,862

61,113

PREPAYMENTS AND ACCRUED INCOME

778

-

CREDITORS

Amounts falling due within one year

(13,700

)

(21,102

)

NET CURRENT ASSETS

19,940

40,011

TOTAL ASSETS LESS CURRENT LIABILITIES

28,256

45,549

ACCRUALS AND DEFERRED INCOME

(2,504

)

(2,513

)

NET ASSETS

25,752

43,036

CAPITAL AND RESERVES

25,752

43,036

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Excelsior Scientific Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

08184604

Registered office:

15 High Street

Brackley

Northamptonshire

NN13 7DH

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £1 sterling .

2.	AVERAGE NUMBER OF EMPLOYEES INCLUDING DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 4 September 2025 and were signed by:

Mr J Goodall - Director